Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5617728 | Journal of Vascular Surgery | 2017 | 8 Pages |
Abstract
TEVAR for iTAA was associated with low perioperative mortality and acceptable 5-year survival at 62.5%. Results were more pessimistic after rTAA repair, however, for which two-thirds of the patients were deceased at 3-year follow-up. Improved selection of patients is necessary to identify patients who are likely to truly benefit from rTAA repair.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tina MD, Anders MD, PhD, Johnny MD, PhD, Kevin MD, PhD,